I've been asked by several PT's in recent weeks to go into some depth and detail as to what I mean by the terms "General Health Screening," "Review of Systems," and "Systems Review"
The General Health Screening that I use is woven into the subjective portion of my evaluation. I will generally ask the following questions:
Fatigue?
Malaise?
Weakness?
Chills/Sweats/Fever? (Low-grade fever of 100 degrees or higher for 2 or more weeks are significant)
Unexplained Weight Loss/Gain (5% increase or decrease over a period of 4 weeks are significant)
Nausea?
Paresthesia/Numbness?
These questions alone won't tell us much, but cross-referenced with additional subjective information and objective findings, serve to raise and eye-brow regarding CONSIDERATION for possible need for referral such as (in order of likelihood in the PT department):
Posts: 3332
Joined: May 11, 2004
From: Michigan
Status: offline
I'm sure Bill Boissonnault's "Screening for Medical Disorders" and "Screening for Medical Disorders, Part 2" would be an exellent option for anyone interested in this topic.... APTA has them both as CD-ROMS: audio-plus. He's great to listen to in person too.
Posts: 3332
Joined: May 11, 2004
From: Michigan
Status: offline
Goodman's most recent version/book of Diff Dx is great. Her first one isn't as user friendly. I have her book in the clinic to help me drill down my questions when someone appears to have something other than musculoskeletal. I met her the other night too! I told her I liked her second book and it was organized WAY better than the 1st one.
I have also looked at differential diagnosis by physical therapists. I treat a lot of dizzy patients using Canalith Repositioning Maneuvers (Epley's) and I get my referrals from Family Practice. Needless to say, many of these patients are presenting with medically complex conditions - including pathology.
I have used Level 1 impact analysis Clinical Decision Rules that were designed for physicians that improve patient safety AND lower cost.
This chart have the rule name, year first published and level of evidence development: